Seres Therapeutics: Q2 Earnings Snapshot
By AP News
Published - Aug 13, 2024, 07:16 AM ET
Last Updated - Aug 13, 2024, 07:16 AM EDT
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Seres Therapeutics Inc. (MCRB) on Tuesday reported a loss of $32.9 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of 22 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.
_____
